Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11998595 Telomerase polypeptide vaccine for treating cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 12, 2019
0
Date of Patent
June 4, 2024
0
Patent Application Number
16712167
0
Patent Citations
‌
US Patent 8796438 Nucleic acids encoding inactive variants of human telomerase
0
‌
US Patent 8858931 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
0
‌
US Patent 9290546 hTERT sequences and methods for using the same
0
‌
US Patent 9376471 HIV consensus envelope sequences and methods for using the same
0
‌
US Patent 9624479 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
0
‌
US Patent 9657068 Telomerase polypeptide vaccine for treating cancer
0
‌
US Patent 10383928 Telomerase polypeptide vaccine for treating cancer
0
‌
US Patent 6916642 Vertebrate telomerase genes and proteins and uses thereof
0
‌
US Patent 7091021 Inactive variants of the human telomerase catalytic subunit
0
‌
US Patent 7199234 Regulatory segments of the human gene for telomerase reverse transcriptase
0
•••
Patent Inventor Names
Gustav Gaudernack
0
Else Marit Inderberg Suso
0
Anne-Marie Rasmussen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11998595
0
Patent Primary Examiner
‌
Brian Gangle
0

Find more entities like US Patent 11998595 Telomerase polypeptide vaccine for treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo